iXgene Inc.
PrivateLast Round
Series A
Jan 5, 2023
Total Funding Raised
$4.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
iXgene Inc. operates in Healthcare & Life Sciences and is based in Japan. Its latest recorded funding round was a Series A round in January 2023.
iXgene Inc. is a biotechnology company that develops innovative cell therapies for intractable diseases, such as malignant brain tumors, by utilizing genome-edited iPS cell-derived neural stem cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iXgene Inc. Comparables
Compare iXgene Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CELLeBRAIN | 80% | |
| Shinobi Therapeutics, Inc. | 79% | |
| Trogenix | 71% |
For institutional investors. Book with your work email.
iXgene Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 5, 2023 | ||||
| Seed | Oct 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
iXgene Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keio Innovation Initiative | Series A |
| MSF Capital Partners | Series A |
| UTokyo Innovation Platform Co., Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 40% MoM.
- Mar 3, 2026
Monthly visitors increased 43% MoM.
For institutional investors. Book with your work email.
iXgene Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about iXgene Inc.'s valuation, stock price, and market status.
Is iXgene Inc. a public or private company?
iXgene Inc. is a private company.
What is the current stock price of iXgene Inc.?
iXgene Inc. is a private company, so its shares have no public market price. Caplight tracks iXgene Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is iXgene Inc. worth (valuation)?
Valuation information for iXgene Inc. is not publicly available.
Can I buy iXgene Inc. stock?
iXgene Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was iXgene Inc.'s last funding round?
iXgene Inc.'s most recent funding round was Series A on January 5, 2023.
Who are the main investors in iXgene Inc.?
Key investors in iXgene Inc. include Keio Innovation Initiative.
Will iXgene Inc. IPO soon?
No public IPO plans have been announced for iXgene Inc..
How can I track iXgene Inc. secondary market activity?
Caplight tracks bids, offers, and trades in iXgene Inc.'s shares on secondary markets.